Form EFFECT Veraxa Biotech Holding
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | February 17, 2026 5:00 P.M. |
| Form: | F-4 | ||||||
| |||||||
| |||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Churches Can Now Turn a Sunday Sermon into a Cinematic Film by Monday: PRAY.COM Opens the AI Studio Behind AI Bible to Every Ministry
- Andrew Horowitz Guest-Hosts No Agenda: Patriot Pellets, 'SI' Rebrand and a FlyDubai Mystery
- Mobix Labs to Host Investor Update Call on Critical Minerals Strategy and Business Outlook
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share